We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-13.48%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$621M
AUM Growth
-$122M
Cap. Flow
-$9.18M
Cap. Flow %
-1.48%
Top 10 Hldgs %
67.64%
Holding
126
New
44
Increased
22
Reduced
9
Closed
47

Sector Composition

Rank Sector Weight
1 Healthcare 59.08%
2 Real Estate 23.64%
3 Financials 12.82%
4 Communication Services 0.91%
5 Industrials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIT
126
DELISTED
CIT Group Inc.
CIT
-118,619
Closed -$6.23M

Similar funds

Crestline Management's Q3 2019 Portfolio in Review

As of Q3 2019, Crestline Management held 126 positions worth $621M, down 16% from $743M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Crestline Management's Q3 2019 filing shows 44 new, 22 increased, 9 reduced and 47 closed positions. Its largest new stake was Federal Realty Investment Trust: 98,293 shares worth $13.4M. The largest sale was VICI Properties, an estimated $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 63% a quarter earlier, followed by Real Estate and Financials.

  • Crestline Management's largest Q3 2019 buy was Federal Realty Investment Trust: 98,293 shares worth $13.4M.
  • Crestline Management added most to Hudson Pacific Properties in Q3 2019, an estimated $6.77M increase.
  • Crestline Management's biggest Q3 2019 reduction was Host Hotels & Resorts, cutting an estimated $10M.
  • Crestline Management fully exited VICI Properties in Q3 2019, selling an estimated $17.2M.
  • Crestline Management's ten largest holdings make up 68% of its $621M portfolio in Q3 2019.
  • Crestline Management opened 44 new positions and closed 47 in Q3 2019.
  • Crestline Management's portfolio value fell 16% quarter-over-quarter to $621M.

Based on Crestline Management's 13F filing for Q3 2019, filed 13 Nov 2019.